Department News

New Portfolio Start-Up: Recolony

Last updated on July 29, 2022 First published on July 28, 2022

Let's welcome a new Start-Up to our portfolio: Recolony - Bacteria-based cancer therapy.

Recolony is a biotech start-up to develop a bacteria-based oral therapy to treat and prevent cancer. The start-up has a novel approach to microbiome-based cancer therapy.

The aim is to improve cancer patient’s medical care and quality of life and reduce health care costs via an optimized treatment approach.

Recolony anticipates that the final product will provide an improved treatment option by reinforcing anti-tumor immune response and regenerating intestinal microbiome composition.


The USZ Health Innovation Hub is proud to add you to the portfolio and support the development of bacteria-based cancer therapy.

Read more about Recolony:

Responsible Department

Health Innovation Hub

To the Department